×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Eliem Therapeutics Inc. (ELYM) NASDAQ

$2.74 (0.02) (-0.73%)

Market Cap: $76.10M

As of 03/28/24 04:00 PM EDT. Market closed.

(ELYM)

Eliem Therapeutics Inc. (ELYM)
NASDAQ

$2.74
(0.02) (-0.73%)

Market Cap: $76.10M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

eliem therapeutics is a biotechnology company delivering therapies that empower patients to live on their own terms. headquartered in seattle with r&d primarily in cambridge, uk, eliem channels its experience, energy, and passion for improving patients’ quality of life by developing and commercializing potentially “best-in-class” drug candidates to treat neuronal excitability disorders. ... read more

eliem therapeutics is a biotechnology company delivering therapies that empower patients to live on their own terms. headquartered in seattle with r&d primarily in cambridge, uk, eliem channels its experience, energy, and passion for improving patients’ quality of life by developing and commercializing potentially “best-in-class” drug candidates to treat neuronal excitability disorders. these conditions—such as chronic pain, depression, epilepsy, and anxiety—cause deep suffering for tens of millions of people each day. at its core, the eliem team is motivated by the promise of helping patients live happier, more fulfilling lives. eliem is a publicly traded company (nasdaq: elym) read our community guidelines here: https://eliemtx.com/community-engagement-guidelines/ read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
11
Address
.
PRICE CHART FOR ELIEM THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.80
Previous Close
$2.76
Days Range
$2.74 - $2.77
52 week range
$2.34 - $3.72
Volume
2,599
Avg. Volume (30 days)
7,541
Market Cap
$76.10M
Dividend Yield
-
P/E
-
Shares Outstanding
27,572,664
Open
$2.80
Previous Close
$2.76
Days Range
$2.74 - $2.77
52 week range
$2.34 - $3.72
Volume
2,599
Avg. Volume (30 days)
7,541
Market Cap
$76.10M
Dividend Yield
-
P/E
-
Shares Outstanding
27,572,664
FINANCIAL STATEMENTS FOR ELIEM THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ELIEM THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Morisset ValerieEVP, R&D AND CSOSep 20, 2023 Option Exercise$0.0020,72814487,460Mar 04, 2024, 11:07 AM
Morisset ValerieEVP, R&D and CSOMar 10, 2023 Option Exercise$0.00316,410523466,732Mar 14, 2023, 05:04 PM
RA CAPITAL MANAGEMENT, L.P.DirectorAug 12, 2021 Buy$12.503,200,00040,000,00010,599,586Aug 16, 2021, 04:47 PM
AI ETI LLC10% OwnerAug 12, 2021 Buy$12.50800,00010,000,0005,009,400Aug 16, 2021, 04:21 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Morisset ValerieEVP, R&D AND CSO09/20/202314
Morisset ValerieEVP, R&D and CSO03/10/2023523
RA CAPITAL MANAGEMENT, L.P.Director08/12/202140,000,000
AI ETI LLC10% Owner08/12/202110,000,000
FUNDS WITH A POSITION IN ELIEM THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RA CAPITAL MANAGEMENT, L.P.13,179,1810.55%0.22%Other
DRIEHAUS CAPITAL MANAGEMENT LLC811,6800.03%No changeGrowth
GEODE CAPITAL MANAGEMENT, LLC66,6260.00002%No changeOther
BLACKROCK INC.31,1450%-0.53%Other
TUDOR INVESTMENT CORP ET AL29,4900.00064%-0.72%Event Driven, Other
RENAISSANCE TECHNOLOGIES LLC10,6030.00004%NewOther
CHANGE IN SHARES OUTSTANDING FOR ELIEM THERAPEUTICS INC
STOCK BUYBACKS FOR ELIEM THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.86%
1Q
09/30/2023
03/31/2023
2.18%
2Q
09/30/2023
12/31/2022
2.64%
3Q
09/30/2023
09/30/2022
2.79%
4Q
09/30/2023
06/30/2022
2.95%
5Q
09/30/2023
03/31/2022
3.17%
6Q
09/30/2023
09/30/2021
73.69%
8Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.86%
1Q
03/31/2023
2.18%
2Q
12/31/2022
2.64%
3Q
09/30/2022
2.79%
4Q
06/30/2022
2.95%
5Q
03/31/2022
3.17%
6Q
09/30/2021
73.69%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ELIEM THERAPEUTICS INC
LOADING...